Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics

• Joseph McEvoy,

  Affiliation Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina, United States of America

  ⨯
• Rebecca A. Baillie,

  Affiliation Rosa & Co LLC, San Carlos, California, United States of America

  ⨯
• Hongjie Zhu,

  Affiliation Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina, United States of America

  ⨯
• Peter Buckley,

  Affiliation Medical College of Georgia, Augusta, Georgia, United States of America

  ⨯
• Matcheri S. Keshavan,

  Affiliation Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Henry A. Nasrallah,

  Affiliation University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America

  ⨯
• George G. Dougherty,

  Affiliation Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Jeffrey K. Yao,

  Affiliations VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Rima Kaddurah-Daouk

  * E-mail: kaddu001@mc.duke.edu

  Affiliation Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina, United States of America

  ⨯